radionuclide therapy

Open Access
Dosimetric evaluation of receptor-heterogeneity on the therapeutic efficacy of peptide receptor radionuclide therapy: correlation with DNA damage induction and in vivo survival
Giulia Tamborino, Julie Nonnekens, Marijke De Saint-Hubert, Lara Struelens, Danny Feijtel, Marion de Jong and Mark W Konijnenberg

Journal of Nuclear Medicine April 9, 2021, jnumed.121.262122; DOI: https://doi.org/10.2967/jnumed.121.262122
You have access
Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: Analysis of the US National Cancer Database
Joseph C Ahn, Marie Lauzon, Michael Luu, Marc L Friedman, Kambiz Kosari, Nicholas Nissen, Shelly C Lu, Lewis R Roberts, Amit G Singal and Ju Dong Yang

Journal of Nuclear Medicine April 9, 2021, jnumed.121.261954; DOI: https://doi.org/10.2967/jnumed.121.261954
Open Access
Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade
Diane S Abou, Amanda Fears, Lucy Summer, Mark Longtine, Nadia Benabdallah, Ryan C. Riddle, David Ulmert, Jeff Michalski, Richard L. Wahl, Denise Chesner, Michele Doucet, Nicholas Zachos, Brian Simons and Daniel LJ Thorek

Journal of Nuclear Medicine April 9, 2021, jnumed.121.261977; DOI: https://doi.org/10.2967/jnumed.121.261977
You have access
Assessing Response to [¹⁷⁷Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, Philipp T Meyer, Cordula Annette Jilg and Juri Ruf

Journal of Nuclear Medicine March 31, 2021, jnumed.120.260836; DOI: https://doi.org/10.2967/jnumed.120.260836
You have access
PSMA-Targeted Therapeutics: A Tale About Law and Economics
Johannes Notni

Journal of Nuclear Medicine March 31, 2021, jnumed.121.262308; DOI: https://doi.org/10.2967/jnumed.121.262308
Open Access
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE
Jonathan R. Strosberg, Rajaventhan Srirajaskanthan, Ghassan El-Haddad, Edward M. Wolin, Beth R. Chasen, Matthew H. Kulke, David L. Bushnell, Martyn E. Caplin, Richard P Baum, Andrew E. Hendifar, Kjell Öberg, Philippe Ruszniewski, Paola Santoro, Per Broberg, Oscar R. Leeuwenkamp and Eric P. Krenning

Journal of Nuclear Medicine March 26, 2021, jnumed.120.258897; DOI: https://doi.org/10.2967/jnumed.120.258897
You have access
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT)
Christopher E Wee, Ayca Dundar, Rachel A Eiring, Mohamed Badawy, Timothy J Hobday, Ayse Tuba Kendi, Annie T Packard and Thorvardur R. Halfdanarson

Journal of Nuclear Medicine March 19, 2021, jnumed.121.262048; DOI: https://doi.org/10.2967/jnumed.121.262048
You have access
First-in-human study of novel SSTR antagonist ¹⁷⁷Lu-DOTA-LM3 for peptide receptor radionuclide therapy in patients with metastatic neuroendocrine neoplasms: dosimetry, safety and efficacy
Richard P. Baum, Jingjing Zhang, Christiane Schuchardt, Dirk Mueller and Helmut Maecke

Journal of Nuclear Medicine March 5, 2021, jnumed.120.258889; DOI: https://doi.org/10.2967/jnumed.120.258889
You have access
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with ¹⁷⁷Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
Rahul V Parghane, Manish Bhandare, Vikram Chaudhari, Shailesh V Shrikhande, Vikas Ostwal, Anant Ramaswamy, Sanjay Talole and Sandip Basu

Journal of Nuclear Medicine February 26, 2021, jnumed.120.258772; DOI: https://doi.org/10.2967/jnumed.120.258772
You have access
Quantitative ⁶⁸Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with ¹⁷⁷Lu-DOTATATE
Claudia Ortega, Rebecca KS Wong, Joshua Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Zhihui Amy Liu and Ur Metser

Journal of Nuclear Medicine February 12, 2021, jnumed.120.256727; DOI: https://doi.org/10.2967/jnumed.120.256727

Main menu

User menu

Search

radionuclide therapy

Pages